Almirall S.A.
Stock Exchange Other OTC
EPS
$0.53
Market Cap
$2.97 B
Shares Outstanding
172.95 M
Public Float
-
Almirall S.A.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
173.85 M
Public Float
-

Profile

Address
Ronda General Mitre, 151
Barcelona Catalonia 08022
Spain
Employees -
Website http://www.almirall.com
Updated 07/08/2019
Almirall SA engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The company operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological and gastrointestinal diseases.

Financials

View All
Created with Highcharts 5.0.14Almirall S.A.Net Income. Fiscal year is January-December. All values EUR Thousands.33 71733 717448 429448 429131 826131 82675 47975 479303 961303 96177 67477 6742013201420152016201720180100k200k300k400k500k
Created with Highcharts 5.0.14Almirall S.A.Sales/Revenue. Fiscal year is January-December. All values EUR Thousands.692 891692 891786 396786 396684 985684 985764 361764 361639 381639 381756 934756 9342013201420152016201720180200k400k600k800k1 000k

Peter Guenter
Chief Executive Officer & Director
Carlos Gallardo Piqué
External Director